This website uses cookies to enhance the user experience.
21st logo
||
V

VIRKELYST AS989 982 893

Limited company
Ivar Aasens vei 30 0373 OSLO, Norge

VIRKELYST AS

Closed at March 12th, 2026
Investering og rådgivning, samt andre tjenester som naturlig faller sammen med dette.
Investere i verdipapirer og dertil tilhørende virksomhet.

Organization

Chairman of the board
Operation time
20 years
- Jul 13, 2006 to Mar 12, 2026
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
100,000
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
1,539,817
NOK
Annual total result 2024
-1,291,542
NOK
Total equity 2024
-1,913,844
NOK
Last update: Jan 14, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-

Others

NameRoleShares
C
CROWE PARTNER REVISJON AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
100 %
directly
Last update: Jan 22, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
100,000
100 %

Shares owned by the VIRKELYST AS

NameShare classTotal number of sharesShare
H
HHK HOLDING AS
Ordinary shares
30,000
100 %
V
VIRKELYST AS
Ordinary shares
100,000
100 %
B
BORGVÆR HOLDING AS
Ordinary shares
30,000
100 %
F
FARVATN MEDINVESTERING 2 AS
Class B shares
159,653
8.26 %
R
RACOM HOLDING AS
Ordinary shares
127,156
4.09 %
F
FINIT TECHNOLOGIES AS
A-shares
46,110
3.14 %
O
OVERO AS
Ordinary shares
1,712
2.38 %
D
DYRKET.NO AS
Ordinary shares
51,006
2.17 %
C
CARBON DYNAMICS AS
Under liquidation
Ordinary shares
20,080
1.61 %
D
DPLAN PROJECT AS
Ordinary shares
800
1.33 %
D
DHARMATECH AS
Ordinary shares
630
1.28 %
B
BEVART AS
Ordinary shares
1,260
0.93 %
E
EXACT THERAPEUTICS AS
Ordinary shares
450,000
0.71 %
A
ARTIFIK AS
Ordinary shares
16,000
0.61 %
A
AGOPRENE AS
Ordinary shares
562
0.45 %
K
KEZZLER AS
Ordinary shares
575,770
0.44 %
F
FARVATN MEDINVESTERING 1 AS
Ordinary shares
109
0.36 %
R
RO LEGACY AS
Ordinary shares
285,026
0.16 %
D
DECISIONS AS
Ordinary shares
9,693
0.15 %
R
REMOVAID AS
Ordinary shares
5,333
0.12 %
P
PREMIUM TRAVEL HOLDING AS
Ordinary shares
13,378
0.09 %
N
NORDIC HALIBUT AS
Ordinary shares
20,140
0.04 %
N
NEXT BIOMETRICS GROUP ASA
Under liquidation
Ordinary shares
18,059
0.02 %
Last update: Sep 25, 2026

Group structure

  • Total operating income 2024: NOK 1,539,817
    Operating profit 2024: NOK 1,230,251
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
1,539,817
1,221,952
1,132,673
1,146,885
Annual Total Result
-1,291,542
-2,930,203
30,780
192,563
Total assets
18,899,105
18,101,574
18,733,656
16,969,936
Total liabilities
20,812,949
18,723,876
16,425,756
14,692,815
Total equity
-1,913,844
-622,302
2,307,901
2,277,121

P&L

Year2024202320222021
Total operating income
1,539,817
1,221,952
1,132,673
1,146,885
Total operating costs
309,566
293,359
299,929
241,211
Operating result
1,230,251
928,593
832,743
905,674
Financial income/costs
-2,521,793
-3,858,795
-742,825
-525,760
Profit before tax
-1,291,542
-2,930,203
89,918
379,914
Total tax & extraordinary income/cost
0
0
59,138
187,351
Annual Total Result
-1,291,542
-2,930,203
30,780
192,563

Balance overview

Year2024202320222021
Total fixed assets
17,310,051
16,840,599
16,550,729
15,405,819
Total current assets
1,589,054
1,260,976
2,182,927
1,564,116
Total assets
18,899,105
18,101,574
18,733,656
16,969,936
Short term debt
11,978,364
10,779,309
9,046,171
7,711,910
Long term debt
8,834,586
7,944,567
7,379,584
6,980,905
Total liabilities
20,812,949
18,723,876
16,425,756
14,692,815
Contributed capital
2,264,800
2,264,800
2,264,800
2,264,800
Retained earnings
-4,178,644
-2,887,102
43,101
12,321
Total equity
-1,913,844
-622,302
2,307,901
2,277,121
Total equity and liabilities
18,899,105
18,101,574
18,733,656
16,969,936

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Standard industrial classification